The Lanier Law Firm Will Appeal Court Reversal of Jury Award to Widow in Nation's 1st Vioxx Trial
HOUSTON, May 29 /PRNewswire/ -- The Lanier Law Firm is announcing its
plans to appeal a decision issued today by the 14th Court of Appeals in
Brazoria County in favor of Whitehouse Station, N.J.-based Merck & Co.
(NYSE: MRK ). In the ruling, the court overturned a jury's determination
Key Vioxx Research Was Written by Merck, Documents Allege
Reports say academics were paid to lend their names to ghost-written studies that exaggerated painkiller's safety
TUESDAY, April 15 (HealthDay News) -- Industry documents reveal that pharmaceutical giant Merck & Co. paid academics to put their names on Vioxx
research published in t...
The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
Mark Lanier, winner of nation's first Vioxx
trial, hails settlement as 'the right thing to do'
HOUSTON, Nov. 9 /PRNewswire/ -- Attorneys from The Lanier Law Firm are
announcing a nationwide settlement agreement with pharmaceutical giant
Merck & Co. Inc. (NYSE: MRK ) th...
Study Points to Cause of Vioxx Heart Risk
The drug ups levels of a protein linked to clotting, researchers say
MONDAY, Aug. 27 (HealthDay News) -- Researchers believe they've zeroed in on what caused Vioxx
to boost users' heart risks.
The popular pain reliever was taken off the market in 2004 because it was linked to a high...
New study may explain Vioxx side-effects Vioxx
and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects. The ne...
Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
HARRISBURG, Pa., May 20 /PRNewswire-USNewswire/ -- Pennsylvania, along
with 28 other states and the District of Columbia, reached a $58 million
settlement, the largest ever for a multi-state consumer protection drug
case, with Merck over allegations of deceptive advertising related to the
Arcoxia Slammed –Nothing Better Than Vioxx Says FD
Drug giant Merck is in trouble again. The Federal Drug Administration of U.S (FDA) has rejected its proposed successor(Arcoxia) to the drug Vioxx, //that was pulled out of the market due to safety reasons.
The arthritis drug Arcoxia which belongs to the same class of drugs as Vioxx
Doctor Grilled In Court For False Report About Vioxx Health Risk
The doctor, who had dismissed increased risk of heart attack associated with Vioxx, has been accused by lawyers who argue that his views are 'out of the mainstream' as it is based on biased research //, funded by the drug company, Merck and Co.
Thomas Cona and John Mcdarby have sued the pharm...
Could Long Tern Vioxx Users Suffer From Heart Attacks?
Dr. Barry Rayburn, a cardiologist from the University of Alabama, Birmingham, told a jury at the latest Vioxx
product liability trial that the drug showed no significant difference in the rate of heart attacks //among its users and those taking similar drugs or placebos. The drug Vioxx
is produced ...
Judgment In Favor Of Merck For Vioxx Drug
Atlantic City jury has given a judgment in favor of Merck the manufacturers of the controversy drug Vioxx
which caused heart attacks in patients who took the drug. The judgment had said that the Merck will not be held liable //for the 2001 heart attack suffered by a man taking the painkiller, but ...
Vioxx in Medical Technology
Vioxx in Medical Definition
...se side-effects) are statistically very significant. If a product, such as vioxx
, has to be recalled from the market, the consequences are far reaching and...oted to the promotion of personalized medicine
TGen , Translational Genomics Research Institute at Arizona State Unive...
Vioxx in Biological News
Pest control research leads to pain control discovery
...ts and found them to be as potent at a low-dose as vioxx
and Celebrex, but without the changes in blood chemistry linked to heart attacks. vioxx
and Celebrex belong to a class of drugs known as C...n in rodents to Vioxx, but also when combined with vioxx
can dramatically reduce the concentrations of the ...
New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds
...OX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and vioxx
in a more complex manner than was previously understood, a Queen's Universi... medications. It is now pointing toward possible alternatives to drugs like vioxx
and Celebrex, says Dr. Funk.
A study published April 13 by The Journal o...
COX-2 inhibitors significantly reduce risk of cancer
...and start taking them until more studies confirm that they are safe and effective," says Harris.
Celebrex is still widely used for pain relief, but vioxx
was pulled off the market in 2004 following reports of heightened risk of heart attacks.
"It's clear that we need to have multiple retrospective an...
Inflammation and drugs to control this activity studied in a variety of tumors sites
...ol of Public Health at The Ohio State University Medical Center in Columbus and his co-workers looked at the use of selective COX-2 inhibitors such as vioxx
and Celebrex between 1999 and 2004 and the incidence of breast cancer. They compared 323 breast cancer cases to 649 healthy controls and found a risk ...
Therapeutic prospects beyond Vioxx
...ied the mechanism by which drugs like Celebrex and vioxx
cause heart problems, in multiple animal models. T...ars ago, FitzGerald noticed that both Celebrex and vioxx
depressed in healthy individuals a protective fat ...GES-1 may retain much of the benefit of drugs like vioxx
and Celebrex, while diminishing the risk of heart ...
Medical whistleblowers speak out
... our soldiers that were killed in the Vietnam war [who] died as a result of vioxx
use. And FDA had the opportunity, the responsibility, to stop that and didn...people have to insist on that, otherwise we're going to have disasters like vioxx
that happen in the future."
Another lesson, says Lenzer, is that "the ra...
FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
This current reexamination of the CV risks of NSAIDs began after Merck conducted a voluntary worldwide withdrawal of its COX-2 selective NSAID, vioxx
(rofecoxib), in September 2004. FDA will carefully review any proposal from Merck for resumption of marketing of Vioxx.
These actions are based on ...
Vioxx in Biological Technology
Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research
... therapy?" Is it because heart patients don't count in politics while AIDS patients do? Or is there another reason why they allow drugs such as vioxx
and forbid risk-free stem cells?
Margolis added that Repair Stems Cells are right now, every week, improving dozens and dozens of lives all over ...
CEL-SCI Corporation Releases Letter to Shareholders
...s are making cancer research a
priority. This is a change from their prior focus on life style,
mass marketed drugs. After the vioxx
debacle and other issues
discovered later, it has become significantly more difficult to
receive FDA approval for life style dru...
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
are simply not always effective and there certainly are side effects with
these medications. As most everyone knows, medications such as vioxx
Celebrex been removed from the market, except in very limited cases. These
drugs, which were initially billed as virtual miracle cures turned out ...
Midwest life-science company Perrigo globalizes under the radar
...ppening in November. Perhaps the trials and tribulations facing Merck after vioxx
have put a sever damper on the market.
A friend told me that the vioxx
effect in a few short days dropped the overall value of Big Pharma companie...
The greatest life-science developments of 2004
...d of biotech and pharmaceuticals, the answer could be:
1. Mercks taking vioxx
off the market due to potent cardiovascular side effects and the resultant ...s said and done (not just due to the resultant loss of sales and profits of vioxx
but also due to the potential class liability suits under way against Merck...
Japan's pharma mergers will trickle to the Midwest
...) was Merck.
Merck has paid the price by slipping from its longtime position as the No. 1 Big Pharma company to seventh place during 2003. With the vioxx
debacle and several drugs going off patent in the next few years, Merck will most likely slip even further in the rankings. All the other leading Big ...
Why are new drugs failing?
...sion to pull Pfizer Cox-2 inhibitor Bextra from the marketplace clearly jolted both Pfizer and the market. Pfizer was initially caught up in the Merck vioxx
dilemma months ago and its stock has declined from $38 per share a year ago to under $25 per share in February. It has recently moved up to the $27 le...
Clinton says world needs biofuels, GM crops, and more answers
...y up to the federal government to decide how much assurance is needed that drugs are safe and effective, especially in the wake of recalls such as the vioxx
"I am committed to using the resources of the Department of Health and Human Services to serve as a rallying point for this patient-centred m...
First half of 2006 roundup: Big Pharma trumps biotech
...ertheless, six of the 10 Big Pharmas had outstanding stock growth, equaling or bettering the Dow Jones, including Merck (which continues to battle the vioxx
lawsuits) and AstraZeneca. Merck received FDA approval for several new vaccines, and has gone on biotech deal spree, which ran contrary to Merck's pri...
FDA: Tortoise, hare, or something else?
... Rep. Waxman's exchange with the Commissioner as a tongue-lashing. However, when there are apparent system failures in succession, such as we saw with vioxx
and now with Avandia, it may be evidence of what the statisticians called systematic error. In seeking the source for such difficulties, the system it...